CanSino Biologics Inc. (CASBF)
OTCMKTS
· Delayed Price · Currency is USD
3.200
-1.400 (-30.43%)
At close: Apr 9, 2025
CanSino Biologics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 847.76 | 824.88 | 345.18 | 1,031 | 4,300 | 18.54 | Upgrade
|
| Other Revenue | 21.45 | 21.45 | 11.9 | 3.55 | - | 6.35 | Upgrade
|
| Revenue | 869.22 | 846.34 | 357.08 | 1,035 | 4,300 | 24.89 | Upgrade
|
| Revenue Growth (YoY) | 134.41% | 137.01% | -65.49% | -75.94% | 17174.82% | 990.04% | Upgrade
|
| Cost of Revenue | 240.27 | 262.76 | 800.83 | 1,218 | 1,298 | 14.73 | Upgrade
|
| Gross Profit | 628.95 | 583.58 | -443.75 | -183.71 | 3,002 | 10.16 | Upgrade
|
| Selling, General & Admin | 557.73 | 547.75 | 639.88 | 535.48 | 327.14 | 95.43 | Upgrade
|
| Research & Development | 392.09 | 416.12 | 637.99 | 778.26 | 878.72 | 428.49 | Upgrade
|
| Other Operating Expenses | -44.12 | -7.14 | -14.16 | -7.24 | 10.18 | 3.91 | Upgrade
|
| Operating Expenses | 913.74 | 962.95 | 1,279 | 1,315 | 1,218 | 527.83 | Upgrade
|
| Operating Income | -284.8 | -379.37 | -1,723 | -1,499 | 1,784 | -517.67 | Upgrade
|
| Interest Expense | -58.32 | -59.98 | -64.15 | -41.34 | -20.42 | - | Upgrade
|
| Interest & Investment Income | 55.23 | 63.87 | 173.26 | 161.89 | 125.42 | 63.76 | Upgrade
|
| Currency Exchange Gain (Loss) | 18.47 | 18.47 | 20.58 | 160.64 | -33.78 | -27.36 | Upgrade
|
| Other Non Operating Income (Expenses) | -20.65 | -5.13 | -105.44 | -0.49 | -0.28 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | -290.08 | -362.14 | -1,698 | -1,218 | 1,855 | -481.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | 37.05 | -43.13 | -14.56 | -4.06 | 71.09 | 6.64 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.85 | 0.77 | 0.18 | - | - | - | Upgrade
|
| Asset Writedown | 4.76 | -1.32 | -363.19 | -0.25 | -0.25 | -0.14 | Upgrade
|
| Other Unusual Items | 24.5 | 24.61 | 96.31 | 38.59 | 10.93 | 78.27 | Upgrade
|
| Pretax Income | -222.92 | -381.2 | -1,979 | -1,184 | 1,937 | -396.64 | Upgrade
|
| Income Tax Expense | -2.58 | 2.47 | -12.07 | -219.24 | 29.7 | - | Upgrade
|
| Earnings From Continuing Operations | -220.33 | -383.67 | -1,967 | -964.76 | 1,907 | -396.64 | Upgrade
|
| Minority Interest in Earnings | - | 4.79 | 484.7 | 55.33 | 7.3 | - | Upgrade
|
| Net Income | -220.33 | -378.88 | -1,483 | -909.43 | 1,914 | -396.64 | Upgrade
|
| Net Income to Common | -220.33 | -378.88 | -1,483 | -909.43 | 1,914 | -396.64 | Upgrade
|
| Shares Outstanding (Basic) | 244 | 248 | 247 | 247 | 247 | 231 | Upgrade
|
| Shares Outstanding (Diluted) | 244 | 248 | 247 | 247 | 247 | 231 | Upgrade
|
| Shares Change (YoY) | -1.38% | 0.38% | -0.17% | -0.08% | 7.26% | 11.79% | Upgrade
|
| EPS (Basic) | -0.90 | -1.53 | -6.01 | -3.68 | 7.74 | -1.72 | Upgrade
|
| EPS (Diluted) | -0.90 | -1.53 | -6.01 | -3.68 | 7.74 | -1.72 | Upgrade
|
| Free Cash Flow | -463.48 | -624.93 | -1,519 | -2,927 | 846.86 | -638.23 | Upgrade
|
| Free Cash Flow Per Share | -1.90 | -2.52 | -6.16 | -11.84 | 3.42 | -2.77 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.800 | - | Upgrade
|
| Gross Margin | 72.36% | 68.95% | -124.27% | -17.76% | 69.82% | 40.82% | Upgrade
|
| Operating Margin | -32.77% | -44.82% | -482.38% | -144.89% | 41.49% | -2079.82% | Upgrade
|
| Profit Margin | -25.35% | -44.77% | -415.23% | -87.90% | 44.52% | -1593.56% | Upgrade
|
| Free Cash Flow Margin | -53.32% | -73.84% | -425.31% | -282.87% | 19.70% | -2564.19% | Upgrade
|
| EBITDA | -113.12 | -193.95 | -1,482 | -1,319 | 1,849 | -498.75 | Upgrade
|
| EBITDA Margin | -13.01% | -22.92% | - | -127.48% | 43.01% | - | Upgrade
|
| D&A For EBITDA | 171.68 | 185.42 | 240.39 | 180.13 | 65.11 | 18.91 | Upgrade
|
| EBIT | -284.8 | -379.37 | -1,723 | -1,499 | 1,784 | -517.67 | Upgrade
|
| EBIT Margin | -32.77% | -44.82% | - | -144.89% | 41.49% | - | Upgrade
|
| Effective Tax Rate | - | - | - | - | 1.53% | - | Upgrade
|
| Revenue as Reported | 869.22 | 846.34 | 357.08 | 1,035 | 4,300 | 24.89 | Upgrade
|
| Advertising Expenses | - | - | - | - | 9.03 | 0.3 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.